IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3037% above fair value
$82.31−1.14 (-1.37%)
Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –
IRadimed shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
IRadimed's shares outstanding was 13M at Sep 30, 2026. For fiscal 2025 it was 13M, up 0.5% from the year before. Over ten years it grew 0.2% a year on average. The highest annual figure on record is 13M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13M | +0.5% |
| FY2024 | Dec 31, 2024 | 13M | +0.5% |
| FY2023 | Dec 31, 2023 | 13M | +0.7% |
| FY2022 | Dec 31, 2022 | 13M | +0.4% |
| FY2021 | Dec 31, 2021 | 13M | +1.2% |
| FY2020 | Dec 31, 2020 | 12M | +1.3% |
| FY2019 | Dec 31, 2019 | 12M | +1.4% |
| FY2018 | Dec 31, 2018 | 12M | +3.3% |
| FY2017 | Dec 31, 2017 | 12M | -2.2% |
| FY2016 | Dec 31, 2016 | 12M | -4.5% |
| FY2015 | Dec 31, 2015 | 13M | +22.9% |
| FY2014 | Dec 31, 2014 | 10M | +18.5% |
| FY2013 | Dec 31, 2013 | 9M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 13M | +0.1% |
| Q2 FY2026 | Jun 30, 2026 | 13M | +0.3% |
| Q1 FY2026 | Mar 31, 2026 | 13M | +0.3% |
| Q4 FY2025 | Dec 31, 2025 | 13M | +0.3% |
| Q3 FY2025 | Sep 30, 2025 | 13M | +0.6% |
| Q2 FY2025 | Jun 30, 2025 | 13M | +0.6% |
| Q1 FY2025 | Mar 31, 2025 | 13M | +0.6% |
| Q4 FY2024 | Dec 31, 2024 | 13M | +0.9% |
| Q3 FY2024 | Sep 30, 2024 | 13M | +0.3% |
| Q2 FY2024 | Jun 30, 2024 | 13M | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | 13M | +0.5% |
| Q4 FY2023 | Dec 31, 2023 | 13M | +0.8% |
| Q3 FY2023 | Sep 30, 2023 | 13M | +0.8% |
| Q2 FY2023 | Jun 30, 2023 | 13M | +0.7% |
| Q1 FY2023 | Mar 31, 2023 | 13M | +0.2% |
| Q4 FY2022 | Dec 31, 2022 | 13M | -0.1% |
| Q3 FY2022 | Sep 30, 2022 | 13M | +0.2% |
| Q2 FY2022 | Jun 30, 2022 | 13M | +0.6% |
| Q1 FY2022 | Mar 31, 2022 | 13M | +1.1% |
| Q4 FY2021 | Dec 31, 2021 | 13M | +1.1% |
| Q3 FY2021 | Sep 30, 2021 | 13M | +0.9% |
| Q2 FY2021 | Jun 30, 2021 | 13M | +4.0% |
| Q1 FY2021 | Mar 31, 2021 | 13M | +1.3% |
| Q4 FY2020 | Dec 31, 2020 | 13M | +1.2% |
| Q3 FY2020 | Sep 30, 2020 | 12M | +1.5% |
| Q2 FY2020 | Jun 30, 2020 | 12M | -1.2% |
| Q1 FY2020 | Mar 31, 2020 | 12M | +1.1% |
| Q4 FY2019 | Dec 31, 2019 | 12M | +0.8% |
| Q3 FY2019 | Sep 30, 2019 | 12M | +0.9% |
| Q2 FY2019 | Jun 30, 2019 | 12M | +1.8% |
| Q1 FY2019 | Mar 31, 2019 | 12M | +2.9% |
| Q4 FY2018 | Dec 31, 2018 | 12M | +4.4% |
| Q3 FY2018 | Sep 30, 2018 | 12M | +4.7% |
| Q2 FY2018 | Jun 30, 2018 | 12M | +2.4% |
| Q1 FY2018 | Mar 31, 2018 | 12M | +10.6% |
| Q4 FY2017 | Dec 31, 2017 | 12M | -0.4% |
| Q3 FY2017 | Sep 30, 2017 | 12M | – |
| Q2 FY2017 | Jun 30, 2017 | 12M | – |
| Q1 FY2017 | Mar 31, 2017 | 11M | – |
| Q4 FY2016 | Dec 31, 2016 | 12M | – |
See a number that looks wrong?